FUNCTIONAL EXPRESSION OF CD47 AND ITS LIGANDS IN TUMOR PLASMACELLS OF MULTIPLE MYELOMA

被引：0
|
作者：
Crisci, S. [1 ]
Galati, D. [1 ]
Iaccarino, G. [1 ]
Di Francia, R. [1 ]
De Monaco, A. [1 ]
Cillo, M. [1 ]
Mele, S. [1 ]
Frigeri, F. [1 ]
Corazzelli, G. [1 ]
De Filippi, R. [1 ,2 ,3 ]
Pinto, A. [1 ]
机构：
[1] IRCCS, Fdn G Pascale, Dept Hematol, Hematol Oncol & Stem Cell Transplantat Unit, Naples, Italy
[2] Univ Naples Federico II, Dept Clin Med & Surg, Naples, Italy
[3] Sch Med, Naples, Italy
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P266
引用
收藏
页码：160 / 160
页数：1
相关论文
共 50 条
  • [1] Dysregulation of CD47 and the ligands thrombospondin 1 and 2 in multiple myeloma
    Danielsen, Jannie M. Rendtlew
    Knudsen, Lene Meldgaard
    Dahl, Inger Marie
    Lodahl, Marianne
    Rasmussen, Thomas
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 138 (06) : 756 - 760
  • [2] Targeting CD47 as a Novel Immunotherapy for Multiple Myeloma
    Sun, Jennifer
    Muz, Barbara
    Alhallak, Kinan
    Markovic, Matea
    Gurley, Shannon
    Wang, Zhe
    Guenthner, Nicole
    Wasden, Katherine
    Fiala, Mark
    King, Justin
    Kohnen, Daniel
    Salama, Noha Nabil
    Vij, Ravi
    Azab, Abdel Kareem
    CANCERS, 2020, 12 (02)
  • [3] High CD47 Protein Expression Is Associated with Inferior Survival in Patients with Multiple Myeloma
    Portrabdollah, Maryam
    Bahmanyar, Mohammad
    Atenafu, Eshetu G.
    Reece, Donna
    Chang, Hong
    LABORATORY INVESTIGATION, 2017, 97 : 371A - 371A
  • [4] High CD47 Protein Expression Is Associated with Inferior Survival in Patients with Multiple Myeloma
    Pourabdollah, Maryam
    Bahmanyar, Mohammad
    Atenafu, Eshetu G.
    Reece, Donna
    Chang, Hong
    MODERN PATHOLOGY, 2017, 30 : 371A - 371A
  • [5] Targeting CD47 As a Novel Therapeutic Strategy in Multiple Myeloma
    Muz, Barbara
    Kusdono, Hubert D.
    King, Justin
    Kohnen, Daniel
    Fiala, Mark A.
    Vij, Ravi
    Capoccia, Ben
    Manning, Pamela T.
    Salama, Noha Nabil
    Azab, Abdel Kareem
    BLOOD, 2017, 130
  • [6] Targeting CD47 as a novel immunotherapy for multiple myeloma.
    Sun, Jennifer
    Muz, Barbara
    Alhallak, Kinan
    Egbulefu, Christopher
    King, Justin
    Kohnen, Danny
    Fiala, Mark
    Cappocia, Benjamin
    Manning, Pamela
    Achilefu, Samuel
    Vij, Ravi
    Azab, Abdel Kareem
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (04) : 29 - 29
  • [7] Inhibition of CD47 as a Novel Cancer Immunotherapy for Multiple Myeloma
    Sun, Jennifer
    Muz, Barbara
    Alhallak, Kinan
    King, Justin
    Kohnen, Daniel
    Fiala, Mark
    Vij, Ravi
    Azab, Kareem
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E153 - E154
  • [8] Exploration of the Therapeutic Effects of CD47 and CD38 Antibody Combination in Relapsed or Refractory Multiple Myeloma (rrMM) and the Correlation with CD47 and CD38 Expression
    Zhang, Yanni
    Sheng, Zhen
    Xia, Jie
    Ye, Chunyan
    Liu, Yan
    Wang, Zhengyi
    Hayslip, John
    Zhu, Andrew
    BLOOD, 2022, 140 : 9937 - 9938
  • [9] Integrin-associated protein (CD47) and its ligands
    Brown, EJ
    Frazier, WA
    TRENDS IN CELL BIOLOGY, 2001, 11 (03) : 130 - 135
  • [10] Imaging of CD47 Expression in Xenograft and Allograft Tumor Models
    Zheleznyak, Alexander
    Ikotun, Oluwatayo F.
    Dimitry, Julie
    Frazier, William A.
    Lapi, Suzanne E.
    MOLECULAR IMAGING, 2013, 12 (08):
12345